Literature DB >> 23914149

The RNA-Binding Protein Musashi1: A Major Player in Intestinal Epithelium Renewal and Colon Cancer Development.

Michelina Plateroti1, Patricia Rosa de Araujo, Acarizia Eduardo da Silva, Luiz O F Penalva.   

Abstract

Aberrant gene expression is the cause and the consequence of tumorigenesis. A major component of gene expression is translation regulation; a process whose main players are RNA-binding-proteins (RBPs). More than 800 RBPs have been identified in the human genome and several of them have been shown to control gene networks associated with relevant cancer processes. A more systematic characterization of RBPs starts to reveal that similar to transcription factors, they can function as tumor suppressors or oncogenes. A relevant example is Musashi1 (Msi1), which is emerging as a critical regulator of tumorigenesis in multiple cancer types, including colon cancer. Msi1 is a stem marker in several tissues and is critical in maintaining the balance between self-renewal and differentiation. However, a boost in Msi1 expression can most likely lead cells towards an oncogenic pathway. In this article, we discuss the parallels between Msi1 function in normal renewal of intestinal epithelium and in colon cancer.

Entities:  

Keywords:  Colon cancer; Musashi1; RNA-binding proteins; Translation regulation

Year:  2012        PMID: 23914149      PMCID: PMC3728701          DOI: 10.1007/s11888-012-0141-6

Source DB:  PubMed          Journal:  Curr Colorectal Cancer Rep        ISSN: 1556-3790


  98 in total

1.  Bmi1 is expressed in vivo in intestinal stem cells.

Authors:  Eugenio Sangiorgi; Mario R Capecchi
Journal:  Nat Genet       Date:  2008-06-08       Impact factor: 38.330

2.  Expression of CD133 and other putative stem cell markers in uveal melanoma.

Authors:  Michelle Thill; Marc Jean Berna; Rebecca Grierson; Inna Reinhart; Tobias Voelkel; Christoph Piechaczek; Peter Galambos; Martine J Jager; Gisbert Richard; Claudia Lange; Ursula M Gehling
Journal:  Melanoma Res       Date:  2011-10       Impact factor: 3.599

3.  Role of the RNA-binding protein HuR in colon carcinogenesis.

Authors:  Isabel López de Silanes; Jinshui Fan; Xiaoling Yang; Alan B Zonderman; Olga Potapova; Ellen S Pizer; Myriam Gorospe
Journal:  Oncogene       Date:  2003-10-16       Impact factor: 9.867

4.  Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivo.

Authors:  Sripathi M Sureban; Randal May; Robert J George; Brian K Dieckgraefe; Howard L McLeod; Satish Ramalingam; Kumar S Bishnupuri; Gopalan Natarajan; Shrikant Anant; Courtney W Houchen
Journal:  Gastroenterology       Date:  2008-03-04       Impact factor: 22.682

5.  Expression of the Musashi1 gene encoding the RNA-binding protein in human hepatoma cell lines.

Authors:  Hong-Jin Shu; Takafumi Saito; Hisayoshi Watanabe; Jun-Itu Ito; Hiroaki Takeda; Hideyuki Okano; Sumio Kawata
Journal:  Biochem Biophys Res Commun       Date:  2002-04-26       Impact factor: 3.575

6.  The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis.

Authors:  Lisa E Young; Sandhya Sanduja; Kristi Bemis-Standoli; Edsel A Pena; Robert L Price; Dan A Dixon
Journal:  Gastroenterology       Date:  2009-01-15       Impact factor: 22.682

7.  Expression of neural stem cell markers in malignant rhabdoid tumor cell lines.

Authors:  Kazuto Okuno; Shigeru Ohta; Hirofumi Kato; Takashi Taga; Kanji Sugita; Yoshihiro Takeuchi
Journal:  Oncol Rep       Date:  2010-02       Impact factor: 3.906

8.  Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling.

Authors:  Nicholas T Ingolia; Sina Ghaemmaghami; John R S Newman; Jonathan S Weissman
Journal:  Science       Date:  2009-02-12       Impact factor: 47.728

9.  The RNA binding protein Musashi1 regulates apoptosis, gene expression and stress granule formation in urothelial carcinoma cells.

Authors:  Parvaneh Nikpour; Modjtaba Emadi Baygi; Christine Steinhoff; Christiane Hader; Anna C Luca; Seyed J Mowla; Wolfgang A Schulz
Journal:  J Cell Mol Med       Date:  2010-05-14       Impact factor: 5.310

10.  Human embryonic and neuronal stem cell markers in retinoblastoma.

Authors:  Gail M Seigel; Abigail S Hackam; Arupa Ganguly; Lorrie M Mandell; Federico Gonzalez-Fernandez
Journal:  Mol Vis       Date:  2007-06-08       Impact factor: 2.367

View more
  5 in total

Review 1.  Stem Cells, Cancer, and MUSASHI in Blood and Guts.

Authors:  Michael G Kharas; Christopher J Lengner
Journal:  Trends Cancer       Date:  2017-04-08

2.  A Mouse Model of Targeted Musashi1 Expression in Whole Intestinal Epithelium Suggests Regulatory Roles in Cell Cycle and Stemness.

Authors:  F M Cambuli; B R Correa; A Rezza; S C Burns; M Qiao; P J Uren; E Kress; A Boussouar; P A F Galante; L O F Penalva; M Plateroti
Journal:  Stem Cells       Date:  2015-09-26       Impact factor: 6.277

3.  Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cells.

Authors:  Caihong Yi; Guiming Li; Dmitri N Ivanov; Zhonghua Wang; Mitzli X Velasco; Greco Hernández; Soni Kaundal; Johanna Villarreal; Yogesh K Gupta; Mei Qiao; Christopher G Hubert; Matthew J Hart; Luiz O F Penalva
Journal:  RNA Biol       Date:  2018-11-18       Impact factor: 4.652

4.  Expression of Musashi-1 Increases in Bone Healing.

Authors:  Miguel Padial-Molina; Vicente Crespo-Lora; Clara Candido-Corral; Nati Martin-Morales; Dario Abril-Garcia; Pablo Galindo-Moreno; Pedro Hernandez-Cortes; Francisco O'Valle
Journal:  Int J Mol Sci       Date:  2021-03-26       Impact factor: 5.923

5.  Interplay among p21Waf1/Cip1, MUSASHI-1 and Krüppel-like factor 4 in activation of Bmi1-CreER reserve intestinal stem cells after gamma radiation-induced injury.

Authors:  Emilia J Orzechowska; Takahito Katano; Agnieszka B Bialkowska; Vincent W Yang
Journal:  Sci Rep       Date:  2020-10-27       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.